Oak Street Health Inc. (OSH) News
Filter OSH News Items
OSH News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OSH News Highlights
- For OSH, its 30 day story count is now at 2.
- Over the past 8 days, the trend for OSH's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- The most mentioned tickers in articles about OSH are EHC.
Latest OSH News From Around the Web
Below are the latest news stories about OAK STREET HEALTH INC that investors may wish to consider to help them evaluate OSH as an investment opportunity.
Encompass Health (EHC) Q1 Earnings and Revenues Surpass EstimatesEncompass Health (EHC) delivered earnings and revenue surprises of 25.71% and 1.18%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock? |
What You Can Learn From Oak Street Health, Inc.'s (NYSE:OSH) P/SWhen close to half the companies in the Healthcare industry in the United States have price-to-sales ratios (or "P/S... |
Oak Street Health Announces Cancellation of its 2023 Annual Meeting of StockholdersCHICAGO, March 30, 2023--Oak Street Health, Inc. (NYSE: OSH or "Oak Street Health"), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, today announced its Board of Directors has cancelled its 2023 Annual Meeting of Stockholders scheduled for Thursday, April 27, 2023, at 8:30 A.M., Central Time (the "Annual Meeting"). |
OakWell Launches to Provide High-Quality Primary Care Directly to Kidney Patients in Dialysis CentersCHICAGO, March 22, 2023-- Oak Street Health (NYSE: OSH), a network of value-based primary care centers for adults on Medicare and the only primary care provider to carry the AARP name, and Interwell Health, a kidney care management company that partners with physicians on its mission to reimagine healthcare, today announced the launch of OakWell, a joint venture that will offer the highest-quality primary care to end-stage kidney disease (ESKD) patients directly in the dialysis center. This uniq |
UPDATE 2-U.S. Senator Warren urges FTC to review CVS-Oak Street dealU.S. Senator Elizabeth Warren has urged the U.S. Federal Trade Commission to review CVS Health Corp's $9.5-billion acquisition of Oak Street Health Inc as well as other merger deals in the sector. The Oak Street buyout is among the company's bigger deals and follows similar acquisitions by rivals Walgreens Boots Alliance, Cigna Corp and UnitedHealth Group Inc as the focus on primary and urgent care delivery has increased since the COVID-19 pandemic. Warren urged the FTC to scrutinize the CVS-Oak Street deal and others like it, retrospectively review similar transactions and "challenge in court any mergers that have reduced competition in violation of antitrust laws". |
How CVS evolved from retail pharmacy into health care behemothCVS came to dominate the retail pharmacy industry and beyond. Some experts wonder whether retail's reach into health care could go too far. |
Oak Street Health Full Year 2022 Earnings: EPS Misses ExpectationsOak Street Health ( NYSE:OSH ) Full Year 2022 Results Key Financial Results Revenue: US$2.16b (up 51% from FY 2021... |
Oak Street Health, Inc. (OSH) Reports Q4 Loss, Tops Revenue EstimatesOak Street Health, Inc. (OSH) delivered earnings and revenue surprises of 9.68% and 1.11%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |
Oak Street Health Reports Full Year 2022 ResultsCHICAGO, February 28, 2023--Oak Street Health, Inc. (NYSE: OSH, or the "Company"), a network of value-based primary care centers for adults on Medicare, today reported financial results for the year ended December 31, 2022. |
The Pennant Group, Inc. (PNTG) Matches Q4 Earnings EstimatesThe Pennant Group, Inc. (PNTG) delivered earnings and revenue surprises of 0% and 6.01%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? |